Results 31 to 40 of about 349,122 (350)

Prevalence of Dyslipidemia and Its Influencing Factors among Elderly Community Residents [PDF]

Zhongguo quanke yixue, 2023
Background Dyslipidemia is the most important and causal independent risk factor for atherosclerotic cardiovascular disease (ASCVD) . The prevalence of dyslipidemia in elderly residents in Guangdong Province is high, and it is urgent to analyze the ...
HUANG Qixian, WEN Yanting, HUANG Jun, LI Weibin, XU Yongneng, LIN Xiayi, WANG Haoxiang, WENG Fan, YANG Lianping
doaj   +1 more source

The Effects of Obesity and Physical Activity on Dyslipidemia in Persons With Type 2 Diabetes [PDF]

The Asian Journal of Kinesiology, 2022
OBJECTIVES This study was conducted to examine the effect of obesity, and physical activity on the prevalence of dyslipidemia in persons with type 2 diabetes mellitus (T2DM). METHODS A cross-sectional, correlational design was used.
Yun-A Shin, Jae-Hyun Kim, Ryuri Song, EunSeok Cha   +3 more
doaj   +1 more source

Exploring metabolic dysfunction in chronic kidney disease [PDF]

, 2012
Impaired kidney function and chronic kidney disease (CKD) leading to kidney failure and end-stage renal disease (ESRD) is a serious medical condition associated with increased morbidity, mortality, and in particular cardiovascular disease (CVD) risk ...
Slee, Adrian D.
core   +2 more sources

Novel findings in relation to multiple anti-atherosclerotic effects of XueZhiKang in humans

Chronic Diseases and Translational Medicine, 2018
Background: Previous studies have clearly demonstrated that XueZhiKang (XZK), an extract of cholestin, can decrease low-density lipoprotein cholesterol (LDL-C) and cardiovascular events. However, the mechanism of the effects of XZK on atherosclerosis (AS)
Rui-Xia Xu, Yan Zhang, Yuan-Lin Guo, Chun-Yan Ma, Yu-Hong Yao, Sha Li, Xiao-Lin Li, Ping Qing, Ying Gao, Na-Qiong Wu, Cheng-Gang Zhu, Geng Liu, Qian Dong, Jing Sun, Jian-Jun Li   +14 more
doaj   +1 more source

The association of body mass index and its interaction with family history of dyslipidemia towards dyslipidemia in patients with type 2 diabetes: a cross-sectional study in Zhejiang Province, China

Frontiers in Public Health, 2023
ObjectivesThis study aimed to investigate the association between body mass index (BMI) and dyslipidemia and to explore the interaction between BMI and family history of dyslipidemia towards dyslipidemia in patients with type 2 diabetes.MethodsThis cross-
Xiang-Yu Chen, Le Fang, Jie Zhang, Jie-Ming Zhong, Jing-Jing Lin, Feng Lu   +5 more
doaj   +1 more source

FABP-2 and PPAR-γ Haplotype as Risk Factors for Dyslipidemia in a Type 2 Diabetes Mellitus Population of Santa Rosa del Conlara, San Luis, Argentina [PDF]

, 2014
Introduction: Type 2 Diabetes Mellitus (T2DM) is a complex disorder caused by the interaction between genetic predisposition and environmental factors. Genetics plays an important role on lipid homeostasis. Many genes are involved in the lipid metabolism,
Fernandez, Gustavo, Gonzalez, Irma Ines, Ojeda, Marta Susana, Olmos Nicotra, Maria Florencia, Siewert, Susana Elfrida   +4 more
core   +1 more source

Dietary inflammation index is associated with dyslipidemia: evidence from national health and nutrition examination survey, 1999–2019

Lipids in Health and Disease, 2023
Background and aims This study aimed to investigate the association between the Dietary Inflammatory Index (DII) and dyslipidemia, as well as to evaluate the mortality risk associated with DII in participants with dyslipidemia.
Xiaozhe Chen, Chunlei Hou, Lei Yao, Jianhua Li, Mingtai Gui, Mingzhu Wang, Xunjie Zhou, Bo Lu, Deyu Fu   +8 more
doaj   +1 more source

Clinicopathological Characteristics and Outcomes of Immunoglobulin A Nephropathy with Different Types of Dyslipidemia: A Retrospective Single-Center Study

Kidney & Blood Pressure Research, 2023
Introduction: Immunoglobulin A nephropathy (IgAN) is one of the most common glomerulonephritic diseases in the world. Several lines of evidence have suggested that dyslipidemia is related to the disease progression and prognosis of IgAN.
Sidi Liu, Zhenzhen Lu, Zhike Fu, Huijie Li, Chuying Gui, Yueyi Deng   +5 more
doaj   +1 more source

Achievement of multiple therapeutic targets for cardiovascular disease prevention. Retrospective analysis of real practice in Italy [PDF]

, 2018
Background: Pharmacological therapy in patients at high cardiovascular (CV) risk should be tailored to achieve recommended therapeutic targets. Hypothesis: To evaluate individual global CV risk profile and to estimate the control rates of multiple ...
American Diabetes Association, Banegas, Bassand, Borghi, Conroy, Easton, Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults, Goldstein, Graham, Grundy, Grundy, Halcox, Kotseva, Mancia, Piepoli, Prugger, Rosengren, Rydén, Sakhuja, Sesti, Thygesen, Tocci, Tocci, Tocci, Tocci, Tocci, Tocci, Van de Werf, Volpe, Volpe, Volpe, Volpe, Whyte, Yusuf   +33 more
core   +1 more source

Intensive genetic analysis for Chinese patients with very high triglyceride levels: Relations of mutations to triglyceride levels and acute pancreatitisResearch in context

EBioMedicine, 2018
Background: Severe hypertriglyceridemia (SHTG, TG ≥5·65 mmol/L), a disease, usually resulting from a combination of genetic and environmental factors, may increase the risk of acute pancreatitis (AP).
Jing-Lu Jin, Di Sun, Ye-Xuan Cao, Hui-Wen Zhang, Yuan-Lin Guo, Na-Qiong Wu, Cheng-Gang Zhu, Ying Gao, Qiu-Ting Dong, Geng Liu, Qian Dong, Jian-Jun Li   +11 more
doaj   +1 more source